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Abstract
Background: Neighboring genes PIK3CA and KCNMB3 are both important for insulin signaling and b-cell function, but their
associations with glucose-related traits are unclear.
Objective: The objective was to examine associations of PIK3CA-KCNMB3 variants with glucose-related traits and potential
interaction with dietary fat.
Design: We first investigated genetic associations and their modulation by dietary fat in the Genetics of Lipid Lowering
Drugs and Diet Network (GOLDN) study (n = 820). Nine single-nucleotide polymorphisms (SNPs) were selected for analysis,
covering more than 80% of the SNPs in the region. We then sought to replicate the findings in the Boston Puerto Rican
Health Study (BPRHS) (n = 844).
Results: For KCNMB3 missense mutation rs7645550, meta-analysis indicated that homeostasis model assessment of insulin
resistance (HOMA-IR) was significantly lower in minor allele T homozygotes compared with major allele C carriers (pooled P-
value = 0.004); for another SNP rs1183319, which is in moderate LD with rs7645550, minor allele G carriers had higher
HOMA-IR compared with non-carriers in both populations (pooled P-value = 0.028). In GOLDN, rs7645550 T allele
homozygotes had lower HOMA-IR only when dietary n-3: n-6 PUFA ratio was low (#0.11, P= 0.001), but not when it was
high (.0.11, P-interaction = 0.033). Similar interaction was observed between rs1183319 and n-3: n-6 PUFA ratio on HOMA-
IR (P-interaction = 0.001) in GOLDN. Variance contribution analyses in GOLDN confirmed the genetic association and gene-
diet interaction. In BPRHS, dietary n-3: n-6 PUFA ratio significantly modulated the association between rs1183319 and
HbA1c (P-interaction = 0.034).
Conclusion: PIK3CA-KCNMB3 variants are associated with insulin resistance in populations of different ancestries, and are
modified by dietary PUFA.
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Introduction
Type 2 diabetes (T2D), one of the most common chronic
diseases in the world, is predicted to affect 285 million adults in
2010 and 439 million adults by 2030 [1]. Insulin resistance (IR) is
central to the development of T2D, and usually precedes diagnosis
of T2D by many years. Observational and intervention studies
suggest that IR could be prevented by dietary and lifestyle
modifications [2], including quantity and quality of dietary fat [3].
However, the beneficial effect of n-3 polyunsaturated fatty acid (n-
3 PUFA) on the prevention of IR and T2D is still controversial [4–
13]. A possible reason for this discrepancy is the fact that genetic
factors alone or through interactions with diets and lifestyle
influence the pathogenesis of IR and T2D [14–16]. Although
numbers of genetic variants associated with IR continue to grow,
relatively few studies have examined the interactions of genetic
variants with fatty acid intake for IR. One of the novel candidate
genes is PIK3CA, encoding phosphatidylinositol 3-kinase (PI3K)
Class-IA p110a catalytic subunit. PI3K is a key mediator of insulin
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signaling and implicated in human diseases including diabetes and
cancer [17]. PI3K is activated by the tyrosine-phosphorylated
insulin receptor substrate following insulin stimulation, and
subsequently catalyzing the formation of phosphatidylinositol
(3,4,5)-trisphosphate, thereby initiating downstream pathways,
leading to glucose uptake and glycogen synthesis [17,18]. PI3K
Class-IA p110a catalytic subunit is the primary insulin-responsive
PI3K isoform [19,20] and is important in growth factor and
metabolic signaling [20,21]. Mice with hepatic knockout of Pik3ca
showed reduced insulin sensitivity, impaired glucose tolerance, and
increased gluconeogenesis [20]. However, the relationships of
PIK3CA mutations with IR in humans and whether any PIK3CA-
nutrient interaction modulates IR are still unclear. The KCNMB3
gene, encoding potassium large conductance calcium-activated
channel (BK channel) M beta member 3, is 5 kbp downstream of
PIK3CA and is in a large linkage disequilibrium (LD) block with
this gene. BK channels are a type of ‘‘large conductance’’ channel
that transports potassium ions (K+) through cell membranes. As
regulators of glucose homeostasis, these channels are important for
b-cell function and regulate insulin secretion [22,23]. To our
knowledge, no studies have reported the association of KCNBM3
variants with IR and the potential interactions of these variants
with dietary fatty acids.
The aim of the present study was to examine the associations
between variants across the PIK3CA-KCNMB3 region and IR and
other glucose-related traits with potential modifications by dietary
fat in a non-Hispanic white population in the Genetics of Lipid
Lowering Drugs and Diet Network (GOLDN) study [24].
Replication of the observed relationships was evaluated in an
independent population of Puerto Rican adults living in Massa-
chusetts and participating in the Boston Puerto Rican Health
Study (BPRHS) [25].
Methods and Materials
Ethics Statement
For GOLDN, the protocol was approved by the Institutional
Review Boards at the University of Alabama, the University of
Minnesota, the University of Utah and Tufts University. For the
BPRHS, the study protocol was approved by the Institutional
Review Boards at Tufts University and Northeastern University.
All the participants gave informed consent.
Study Populations
The GOLDN study (n= 820) consisted of 406 men and 414
women. All participants were of European origin, recruited from
two National Heart, Lung, and Blood Institute Family Heart
Study field centers (Minneapolis, MN, and Salt Lake City, UT)
[26]. The study design and methodology were described
previously [24]. Subjects were asked to take the lipid lowering
drug (micronized fenofibrate, 160 mg) in a three-week unblinded
clinical trial. The registration identifier is NCT00083369 (http://
www.clinicaltrials.gov/ct2/show/NCT00083369). Clinical and
biochemical parameters were collected before and after the
intervention, and all the fasting blood biochemical parameters
used in the present study were from the second visit before the
intervention.
The replication study included 844 participants (239 men, 605
women) from the BPRHS, with almost complete genotype and
dietary assessment data. The study details were described in detail
previously [25]. Briefly, the BPRHS is a longitudinal cohort study
for stress, nutrition, health, and aging, for which participants who
self-identified as Puerto Rican and lived in the Boston metropol-
itan area were recruited. Ancestry composition of the BPRHS is
57.2% European, 27.4% African, and 15.4% Native American
[27].
Data Collection
In GOLDN, dietary information was collected by a Diet
History Questionnaire (DHQ) developed by the National Cancer
Institute, based on national dietary data (USDA Continuing
Survey of Food Intakes by Individuals). The DHQ has been
validated in two studies [28,29]. In the BPRHS, dietary intake was
assessed by a validated Food Frequency Questionnaire (FFQ)
designed for and tested in this population [30], and nutrient
analyses were linked to the Minnesota Nutrient Data system (1999,
version 25). Importantly, PUFA intakes have been validated for
both populations [27,28,29] and measures of erythrocyte mem-
brane PUFA content in GOLDN is significantly correlated with
dietary PUFA (r = 0.11, P= 0.002). Lifestyle and demographic
information, medication use and medical history were obtained in
each population by questionnaire. Anthropometric measurements
were taken at the baseline visit. Height, body weight and waist
circumference were all measured by standard techniques. Body
mass index was calculated as weight (kg)/height (m)2. T2D was
defined based on a fasting plasma glucose concentration
$126 mg/dL or use of insulin or other diabetes medication.
Laboratory Methods
Blood samples were drawn after an overnight fast. In GOLDN,
fasting insulin was measured by a commercial kit using a
radioimmunoassay (Linco Research, St. Charles, MO), fasting
glucose was determined by a hexokinase-mediated reaction on the
Hitachi commercial kit (Linco Research, St. Charles, MO). In the
BPRHS, measurements of fasting insulin, glucose and glycosylated
hemoglobin (HbA1c) have been described in details previously
[25]. Homeostasis model assessment of IR (HOMA, fasting
glucose6fasting insulin/22.5) was used to assess IR in both
populations.
Single-nucleotide Polymorphism Selection, Genotyping
and Haplotype Analysis
Nine tag single-nucleotide polymorphisms (SNP) were selected
using Tagger [31] based on HapMap Caucasian European Utah
data (www.hapmap.org) in the Haploview program (version 4.2)
with a minor allele frequency $0.05 and r2.0.80. The selected
SNPs covered more than 80% of all SNPs in the region (160 kbp),
ranging from 50 kbp upstream of the PIK3CA gene to 25 kbp
downstream of the gene and covering KCNMB3. LD of the
selected SNPs were estimated as correlation coefficients (r2) using
Haploview (Figure S1). Haplotype of these SNPs were also
estimated by Haploview.
DNA was isolated from blood samples using Gentra Puregene
Blood Kits (Gentra Systems) in GOLDN and QIAamp DNA
Blood Mini Kits (Qiagen) in the BPRHS. In GOLDN, genome-
wide genotyping was conducted by using Affymetrix Genome-
Wide Human SNP Array 6.0. MACH (Markov Chain based
haplotyper V1.0.16, http://www.sph.umich.edu/csg/abecasis/
MaCH/) was used to impute all autosomal SNPs using the phased
haplotypes for CEU from HapMap (release 22, build 36) as a
reference panel. In the BPRHS, genome-wide genotyping was
conducted by using Illumina HumanOmni5-Quad GWAS arrays.
Selection of SNPs for Replication in the BRPHS and
Population Admixture
Two SNPs: rs7645550 and rs1183319 were selected for
replication in BPRHS based on evidence of significant relation-
PUFA-Gene Interaction on Insulin Resistance
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ships in GOLDN. One SNP, rs7645550, is a missense mutation in
the KCNMB3 gene. The second SNP, rs1183319 is located in the
59UTR of KCNMB3 gene. In the BPRHS population, the
population admixture was estimated previously based on 100
SNPs that were selected as ancestry informative [27]. All the
genotype-associated analyses were adjusted for the population
admixture in the present study.
Statistical Analyses
Statistical analyses were performed using SAS (version 9.2) and
R software (version 2.15.0). HOMA-IR, insulin, glucose and
HbA1c were Box-Cox transformed [32] to achieve normal
distribution prior to statistical analysis. Chi-square tests were
conducted to examine whether the selected SNPs were in Hardy-
Weinberg equilibrium. Due to the limited sample size, a dominant
model was applied in the final analysis to increase statistical power
for all SNPs, except for rs7645550, which followed a clear
recessive model for HOMA-IR (HOMA-IR=3.18, 3.67, and 3.71
for TT, CT and CC carriers, respectively). The minor allele was
always treated as the reference allele in the models. The
correlations of dietary fatty acids with glucose-related traits were
assessed using a Pearson correlation coefficient after controlling for
potential confounders. Dietary total fat, saturated fatty acid (SFA),
monounsaturated fatty acids (MUFA), total PUFA, n-3 PUFA, n-6
PUFA and n-3: n-6 PUFA ratio were dichotomized based on the
median intake of each population for the gene-nutrient interaction
analysis. In GOLDN, the family relationships within the
population were adjusted using the SAS GENMOD procedure,
assuming an exchangeable correlation structure within pedigree. A
multivariate interaction model was used to test the interactions of
fatty acid intake with genetic variants after adjustment for age, sex,
waist circumference, alcohol drinking, smoking status, physical
activity, T2D and study center in the GOLDN population. In the
BPRHS, using linear regression model, similar genotype associ-
ations and interactions were tested for selected SNPs while
adjusting for age, sex, waist circumference, alcohol drinking,
smoking status, physical activity, T2D and population admixture.
Variance contribution of the genetic effect and the gene-nutrient
interaction for HOMA-IR were estimated using a GWAF package
[33] in R.
Meta-analysis was conducted with the Meta-Analysis Helper
(METAL) (http://www.sph.umich.edu/csg/abecasis/metal/) un-
der fixed-effects models, and combining the z-statistics across the
two populations, weighted by sample size. Meta-analysis was only
conducted to summarize the results from main genetic association,
but not for gene-nutrient interaction, as the dietary intake range
and FFQ used are substantially different between the two
populations. To correct for multiple testing, Bonferroni adjust-
ment was used. As our primary interest is insulin resistance, we
only applied Bonferroni correction for HOMA-IR. The pertinent
number of correction due to multiple testing is 63 (769), and the
corrected P-value for a significant interaction is 0.0008 (0.05/63).
Results
Characteristics of the Populations and Genetic Variants at
PIK3CA-KCNMB3
Men had significantly higher total energy and MUFA intake
than women in both GOLDN and the BPRHS populations
(Table 1). In GOLDN, none of the nine SNPs deviated from
Hardy-Weinberg equilibrium expectations (P.0.01), with the
minor allele frequencies ranging from 0.07 to 0.49 (Table S1). In
the BPRHS, the minor allele frequency of rs7645550 (T) and
rs1183319 (G) was 0.36 and 0.45, respectively, and did not deviate
from Hardy-Weinberg equilibrium expectations (P.0.01). SNPs
rs7645550 and rs1183319 were in moderate LD in both GOLDN
(r2 = 0.54) and BPRHS (r2 = 0.44). Three haplotypes were
observed for this pair of SNPs: CG, TA, and CA, and the
corresponding frequency was 0.45, 0.40 and 0.15 in GOLDN, and
0.45, 0.36 and 0.20 in BPRHS.
Associations between PIK3CA-KCNMB3 Variants and
Glucose-related Traits
Meta-analysis indicated that SNP rs7645550 minor allele T
homozygotes had significantly lower HOMA-IR (z-score = 2.86,
pooled P-value = 0.004), insulin (z-score = 2.33, pooled P-val-
ue = 0.02) and glucose concentration (z-score = 2.83, pooled P-
value = 0.005) compared with major allele C carriers (Table 2).
For SNP rs1183319, minor allele G carriers had significantly
higher HOMA-IR (z-score = 2.19, pooled P-value = 0.028) and
glucose concentration (z-score = 3.14, pooled P-value = 0.002)
compared with major allele A homozygotes.
Associations between Dietary Fatty Acids and Glucose-
related Traits
In GOLDN, the ratio of dietary n-3: n-6 PUFA was positively
correlated with the fasting glucose concentration (r = 0.081,
P=0.023) after controlling for age, sex, waist circumference,
alcohol drinking, smoking status, physical activity, T2D and study
center. In the BPRHS, this ratio was inversely correlated with
HOMA-IR (r =20.069, P=0.05) and insulin (r =20.073,
P=0.039), and dietary n-3 PUFA was inversely correlated with
insulin (r =20.072, P=0.042) after controlling for age, sex, waist
circumference, alcohol drinking, smoking status, physical activity,
T2D and population admixture. Other dietary fatty acid intakes,
such as total fat, SFA, MUFA, PUFA, n-3 PUFA, and n-6 PUFA,
were not correlated with glucose-related traits in the GOLDN or
in the BPRHS population.
Interactions of PIK3CA-KCNMB3 Variants with Dietary
Fatty Acids on Fasting Glucose and HbA1c
Genotype by diet interactions between PIK3CA-KCNMB3
variants and dietary total fat, SFA, MUFA, PUFA, n-3 PUFA,
n-6 PUFA and n-3: n-6 PUFA ratio for glucose-related traits were
examined. Dietary fatty acids were expressed as percentage of total
energy intake and dichotomized into categorical variables based
on the median intake of the population. In GOLDN, SNP
rs1183319 had significant and marginally significant interactions
with dietary MUFA (P=0.014) and PUFA (P=0.051) for fasting
glucose (data not shown). Other genetic variants did not interact
with fatty acid intakes for glucose concentration.
In BPRHS, dietary n-3: n-6 PUFA ratio significantly modulated
the association between rs1183319 and HbA1c (P=0.034) (Table
S2). The G allele carriers had higher HbA1c compared with A
homozygotes when the n-3: n-6 ratio was high (.0.09, P=0.011),
but not when the ratio was low (#0.09, P=0.635).
Interactions of PIK3CA-KCNMB3 Variants with Dietary
Fatty Acids for HOMA-IR and Insulin
In GOLDN, significant interactions between dietary PUFA and
PIK3CA-KCNMB3 variants for HOMA-IR were observed
(Table 3, Figure 1). SNPs rs7645550 and rs1183319 signifi-
cantly interacted with the n-3: n-6 ratio to modulate HOMA-IR
(P=0.033 for rs7645550, P=0.001 for rs1183319) and insulin
(P=0.018 for rs7645550, P=0.004 for rs1183319). SNP
rs7645550 minor allele T homozygotes had lower HOMA-IR
than C allele carriers (P=0.001) only when the n-3: n-6 ratio was
PUFA-Gene Interaction on Insulin Resistance
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low (#0.11) (Figure 1). Minor allele G carriers of rs1183319 had
significantly higher HOMA-IR than non-carriers when the dietary
n-3: n-6 PUFA ratio was low (#0.11, P,0.001), and not when the
ratio was high (.0.11, P=0.368) (Table 3).
Table 1. Characteristics of participants in GOLDN and the BPRHS1.
Characteristics GOLDN BPRHS
Men (n=406) Women (n=414) Men (n =239) Women (n=605)
Age, y 48.8615.9 49.0616.1 57.667.7 58.167.1
BMI, kg/m2 28.664.7 28.466.2 29.965.1 33.067.0*
Waist circumference, cm 101614 93.4617.5* 102614 102616
Current smoker, n (%) 33 (8.1) 34 (8.2) 70 (29.9) 112 (18.7)*
Current drinker, n (%) 199 (49) 208 (50.2) 121 (50.6) 196 (32.4)*
Type 2 diabetes, n (%) 33 (8.1) 26 (6.3) 106 (44.4) 254 (42.0)
Energy intake, kJ/d 1048166282 745063419* 1213466353 920064874*
Total fat intake, % 35.966.7 35.166.9 32.466.0 31.465.5
Saturated fat intake, % 12.162.7 11.662.6* 9.862.7 9.462.3
MUFA intake, % 13.662.8 13.062.8* 11.362.2 10.862.1*
PUFA intake, % 7.462.0 8.062.3* 8.862.1 8.662.1
n-3 PUFA intake, % 0.6860.19 0.7560.23* 0.6960.18 0.7160.19
n-6 PUFA intake, % 6.6461.83 7.1462.16* 8.0761.99 7.9162.00
n-3: n-6 0.1060.02 0.1160.02 0.0960.02 0.0960.03
HOMA-IR 3.8762.63 3.3762.31* 5.9567.69 5.8067.16
Glucose, mmol/L 5.8761.19 5.4660.94* 6.9362.91 6.7762.83
Insulin, pmol/L 101658 94.5656.5 1246117 1256113
HbA1c, % NA NA 7.0961.96 7.1161.78
1Values are mean 6 SD, or n (%).
*P,0.01 different from men within the population; HbA1c, glycosylated hemoglobin; NA, not available.
doi:10.1371/journal.pone.0067394.t001
Table 2. Associations between PIK3CA-KCNMB3 variants and glucose-related traits in the GOLDN and BPRHS participants1.
Genotypes (n) GOLDN BPRHS Meta-analysis
Mean 6 SEM (n) P-value Mean 6 SEM (n) P-value Z-score P-value I2 (%)
HOMA-IR
rs7645550 CC+CT 3.6960.10 (698) 0.004 5.9360.28 (730) 0.234 2.86 0.004 31.6
TT 3.1860.19 (122) 5.3360.62 (113)
rs1183319 AG+GG 3.6660.10 (571) 0.060 5.9760.29 (680) 0.240 2.19 0.028 0
AA 3.5060.16 (249) 5.4160.47 (159)
Insulin
rs7645550 CC+CT 99.462.2 (698) 0.048 12664 (730) 0.185 2.33 0.02 0
TT 88.564.5 (122) 117611 (113)
rs1183319 AG+GG 98.562.4 (571) 0.319 12765 (680) 0.483 1.20 0.229 0
AA 96.063.7(249) 11868 (159)
Glucose
rs7645550 CC+CT 5.7060.04 (698) 0.0001 6.8060.11 (730) 0.895 2.83 0.005 86.1
TT 5.4660.09 (122) 6.9060.27 (113)
rs1183319 AG+GG 5.6860.04 (571) 0.008 6.8460.11 (680) 0.120 3.14 0.002 0
AA 5.6260.08 (249) 6.7360.21 (159)
1Values are mean 6 SEM. P-values were adjusted for age, sex, waist circumference, alcohol drinking, smoking status, physical activity, type 2 diabetes, study center and
family relationships in GOLDN; P-values were adjusted for age, sex, waist circumference, alcohol drinking, smoking status, physical activity, type 2 diabetes and
population admixture in BPRHS. Meta-analysis was used to combine Z statistics across GOLDN and the BPRHS, weighted by the sample size; I2 was used to assess
statistical heterogeneity: I2 values of 25%, 50% and 75% correspond to cut-off points for low, moderate and high degrees of heterogeneity.
doi:10.1371/journal.pone.0067394.t002
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In addition to rs7645550 and rs1183319, SNP rs7642066 was
found to interact significantly with dietary PUFA, MUFA, n-6
PUFA, and the n-3: n-6 ratio on HOMA-IR (Table 3).
Furthermore, rs2677764 showed a significant interaction with
dietary n-3 PUFA to modulate HOMA-IR (P=0.020, data not
shown) in GOLDN. No significant interactions between
rs7645550 and rs118339 and dietary fat for HOMA-IR in the
BPRHS were observed.
Variance Contributions by GxE Interaction for HOMA-IR in
GOLDN
Genotype by environment (GxE) interactions may contribute
substantially to phenotypic variation, as the main genetic effect
usually inadequately explains phenotypic variation. In order to
examine the portion of phenotypic variation explained by the
PIK3CA-KCNMB3 variants and their interaction with diet, the
GWAF package in R was used to examine the variance
contribution in GOLDN, after controlling for potential confound-
ers. We estimated the variance contribution by the GxE
interaction of the n-3: n-6 PUFA ratio with the PIK3CA-KCNMB3
variants to the total HOMA-IR variance, as this ratio was the most
important dietary factor affecting the main genetic effect for
HOMA-IR in the present study. The total portion of HOMA-IR
variation explained by PIK3CA-KCNMB3 variants (six independent
SNPs, with r2,0.20 were selected: rs3975506, rs2677760,
rs2677764, rs1170672, rs1183319, and rs7642066) was 1.91%,
and that explained by the interaction of PIK3CA-KCNMB3 variants
with dietary n-3: n-6 PUFA ratio was 1.78% (Table S3).
Discussion
In the present study, we found that genetic variants at the
PIK3CA-KCNMB3 region associated with glucose-related traits,
and had significant interactions with dietary PUFA to modulate
these traits, especially HOMA-IR. SNP rs7645550 minor allele T
Figure 1. Interactions between rs7645550 and dietary n-3: n-6
PUFA ratio on HOMA-IR and insulin in GOLDN. When dietary n-3:
n-6 PUFA ratio was low (#0.11), there were significant differences by
genotypes for HOMA-IR (P= 0.001) and insulin (P= 0.003), while no
significant differences for HOMA-IR (P=0.86) and insulin (P= 0.56) were
observed among the rs7645550 genotypes when dietary n-3: n-6 PUFA
ratio was high (.0.11). The number inside the bar indicates the number
of participants with a given genotype.
doi:10.1371/journal.pone.0067394.g001
Table 3. Interactions between dietary fatty acids and PIK3CA-KCNMB3 variants on HOMA-IR in the GOLDN participants1.
Dietary
fatty acids % energy rs1183319 rs7642066
AG+GG (n) AA (n) P-trend
P –
interaction2 AA+AT (n) TT (n) P -trend
P -
interaction2
Total fat #35.66 3.4060.12 (289) 3.6060.22 (120) 0.467 0.003 3.5260.13 (287) 3.3260.16 (122) 0.278 0.045
.35.66 3.9460.17 (281) 3.4160.22 (128) ,0.001 3.6260.15 (282) 4.1360.30 (127) 0.105
Total MUFA #13.23 3.4960.15 (278) 3.5760.21 (131) 0.601 0.009 3.5260.14 (287) 3.5260.25 (122) 0.097 0.002
.13.23 3.8360.15 (292) 3.4360.24 (117) 0.002 3.6260.15 (282) 3.9360.23 (127) 0.013
Total SFA #11.82 3.5860.14 (290) 3.5460.23 (119) 0.957 0.024 3.5260.14 (285) 3.6760.22 (124) 0.951 0.855
.11.82 3.7660.16 (280) 3.4760.22 (129) 0.003 3.6260.14 (284) 3.7760.27 (125) 0.785
Total n-3 PUFA #0.68 3.4960.13 (289) 3.3760.19 (120) 0.293 0.588 3.5660.13 (286) 3.2160.17 (123) 0.227 0.059
.0.68 3.8560.17 (281) 3.6260.25 (128) 0.063 3.5760.15 (283) 4.2460.29 (126) 0.115
Total n-6 PUFA #6.60 3.5560.12 (280) 3.4260.17 (129) 0.498 0.197 3.6160.12 (292) 3.2760.18 (117) 0.129 0.008
.6.60 3.7860.17 (290) 3.6060.27 (119) 0.015 3.5360.16 (277) 4.1560.28 (132) 0.018
n-3: n-6 #0.11 3.8160.16 (299) 3.0560.17 (110) ,0.001 0.001 3.4660.13 (272) 3.9060.27 (137) 0.040 0.018
.0.11 3.5060.13 (271) 3.8660.25 (138) 0.368 3.6760.15 (297) 3.5160.19 (112) 0.178
Total PUFA #7.34 3.5760.13 (282) 3.4260.18 (127) 0.466 0.240 3.6360.12 (293) 3.2660.18 (293) 0.119 0.008
.7.34 3.7660.17 (288) 3.5960.27 (121) 0.022 3.5060.16 (276) 4.1460.28 (133) 0.018
1Values are mean 6 SEM.
2P-values were derived from a multivariate interaction model, after adjustment for age, sex, waist circumference, alcohol drinking, smoking status, physical activity, type
2 diabetes, study center and family relationships.
doi:10.1371/journal.pone.0067394.t003
PUFA-Gene Interaction on Insulin Resistance
PLOS ONE | www.plosone.org 5 June 2013 | Volume 8 | Issue 6 | e67394
homozygous carriers had lower HOMA-IR compared with major
allele C carriers in both European-American (GOLDN) and
Puerto Rican (BPRHS) populations. For rs1183319, minor allele
G carriers had higher HOMA-IR compared with non-carriers in
both populations. In addition, both of these two SNPs interacted
with dietary n-3: n-6 PUFA ratio on HOMA-IR in the GOLDN
population.
Previous studies reporting associations between IR, T2D and n-
3 PUFA intake are inconclusive. Some studies found that n-3
PUFA was inversely associated with IR and risk of T2D [6,8,9],
while others found n-3 PUFA was positively associated with IR
and risk of T2D [5,7] or had no effect on IR or T2D [4,13].
Recent meta-analyses of randomized controlled trials found that n-
3 PUFA supplementation had no significant effects on IR or
glycemic control [11,12]. Meta-analyses based on prospective
studies consistently concluded that overall fish and n-3 PUFA
intake were not associated with risk of T2D [10,34,35]. The
number of genetic variants demonstrated to contribute to IR and
T2D continues to expand [36,37] and a growing number of
variants have been shown to be influenced by interactions with
dietary factors [36,38–42]. Genetic variants in genes including
ACSL1, ADIPOQ, ADIPOR1, CLOCK, PLIN1, TCF7L2, and LEPR
[42] were found to interact with dietary fatty acids to modulate IR.
Hence, inconsistent associations between n-3 PUFA and IR or
T2D may be partly attributed to the influence of gene-nutrient
interaction [14–16]. In the present study, the associations between
dietary fatty acids and IR were inconsistent across the GOLDN
and BPRHS populations. Dietary n-3: n-6 PUFA ratio was
inversely correlated with IR in BPRHS, but not in GOLDN; while
n-3: n-6 PUFA ratio was positively correlated with glucose in
GOLDN. Interactions between PIK3CA-KCNMB3 variants and n-
3: n-6 PUFA ratio may contribute to such inconsistencies. The
different interaction patterns may be due to differences in fatty
acid intake between the two populations. For example, the mean
dietary intake of n-3: n-6 PUFA ratio (0.10660.020) in GOLDN
was higher than the mean intake of n-3: n-6 PUFA ratio
(0.09260.027) in the BPRHS. On the other hand, .40% of the
participants in BPRHS had T2D and most of the T2D patients
took diabetes medication, which may be an important source of
the different observations between the two populations. In
addition, distinction in both genetic background and culture,
especially as related to food choices and preparation methods,
between the BPRHS and GOLDN populations could affect the
observed interactions [27].
Four PIK3CA-KCNMB3 variants were found to interact with n-
3: n-6 PUFA ratio or n-3 PUFA in the GOLDN population. The
threshold for the Bonferroni correction was 0.0008, and the
interaction of rs1183319 with the n-3: n-6 PUFA ratio on HOMA-
IR (P=0.001) marginally passed the Bonferroni correction.
Furthermore, these results of gene-nutrient interactions were
confirmed with variance contribution analysis, and variance
contribution analysis indicated that the interaction of PIK3CA-
KCNMB3 variants with n-3: n-6 PUFA ratio contributed a similar
proportion of the HOMA-IR variance as did the main genetic
effects. The mechanisms through which dietary n-3 PUFA
modulated the association of these variants with IR and other
glucose-related traits are still unclear. It is well known that n-3
PUFA and their metabolites are natural ligands for peroxisome
proliferator receptor activator (PPAR) c, and PPAR-c is reported
to regulate insulin sensitivity and glucose homeostasis through
different mechanisms [43,44]. It is predicted by the MAPPER
transcription factor binding site prediction tool (http://mapper.
chip.org) that the KCNMB3 promoter has a PPAR-c -retinoid X
receptor complex binding site, through which n-3 PUFA may
influence KCNMB3 gene expression and interact with KCNMB3
variants to influence IR. In addition, n-3 PUFA (docosahexaenoic
acid) was reported to activate vascular BK channels dependent on
the cytochrome P450 epoxygenase activity [45], and this
mechanism may support the interactions of n-3 PUFA with
genetic variants at KCNMB3 to influence activity of BK channels.
However, more research is needed to elucidate a precise
mechanism.
Despite the different genetic backgrounds of the two popula-
tions, PIK3CA-KCNMB3 variants (rs7645550 and rs1183319) were
found to be associated with glucose-related traits in both
populations in the current study. Both SNPs are located in the
KCNMB3 gene: rs7645550 is a missense mutation (Ala to Thr) and
rs1183319 maps to the 59-UTR. Importantly, the missense
mutation of rs7645550, which changes an alanine conserved from
mammals to amphibians to a threonine is predicted by PolyPhen-2
[46] to be ‘‘probably damaging’’. Previous GWAS [47] indicated a
tendency of association between rs1183319 (P=0.08), rs7645550
(P=0.198) and HOMA-IR (http://www.magicinvestigators.org/
downloads/). These non-significant associations may be due to the
influence of dietary factors, as suggested by this study. It is
reasonable to postulate that KCNMB3 variants may affect IR and
glucose metabolism through BK channels. KCNMB3, encodes BK
channel subunit 3, and variants at KCNMB3 were shown to affect
BK channel activity [48]. An animal study [22] suggested that BK
channel knockout (BK-KO) mice displayed markedly impaired
glucose tolerance and insulin secretion through effects on b-cell
function. BK channels were also reported to regulate insulin
secretion in mouse pancreatic beta-cells [23]. However, no study
so far has reported associations between KCNMB3 variants and IR
or other glucose-related traits. Studies in additional populations
are needed to further replicate these associations. Apart from
KCNMB3, PIK3CA variant (rs2677760) was also reported to be
associated with IR in the GOLDN population. PIK3CA is critical
in the insulin transduction pathway and dysfunction of PIK3CA
may lead to IR and impaired glucose tolerance, as suggested by
evidence from the hepatic Pik3ca knockout mice [20]. However,
rs2677760 is in the intron of the PIK3CA gene, and its function is
still unclear.
Although there were significant associations between PIK3CA-
KCNMB3 variants and glucose-related traits in both GOLDN and
BPRHS populations, and PIK3CA-KCNMB3 variants were found
to interact with PUFA, our results should be interpreted
cautiously. First, the moderate sample sizes in both populations
limit statistical power. Second, the associations between PIK3CA-
KCNMB3 variants and glucose-related traits and the modulation
by dietary fatty acids were reported for the first time in the current
study. Further replication in other populations is warranted.
In conclusion, we observed that PIK3CA-KCNMB3 variants were
associated with the glucose-related traits in populations of
European-American and Puerto Rican ancestry. Dietary PUFA,
especially the n-3: n-6 PUFA ratio, modulated the effects of
PIK3CA-KCNMB3 variants on the glucose-related traits.
Supporting Information
Figure S1 Linkage disequilibrium (LD) plot across
PIK3CA-KCNMB3 region in CEU population. The hori-
zontal white bar depicts the 160-kb DNA segment analyzed in the
sample. An LD plot is presented at the bottom of the figure: each
diamond represents the magnitude of LD for the single pair of
markers. The numbers under the variant name and above the plot
indicates the order of the corresponding variants among all the
PUFA-Gene Interaction on Insulin Resistance
PLOS ONE | www.plosone.org 6 June 2013 | Volume 8 | Issue 6 | e67394
variants in the region. The numbers inside the diamonds indicate
the r2 value.
(DOCX)
Table S1 Description of selected variants in PIK3CA-
KCNMB3 region in GOLDN.
(DOCX)
Table S2 Interactions between dietary PUFA and
rs1183319 on fasting glucose and HbA1c in the BPRHS
participants.
(DOCX)
Table S3 Variance contributions of PIK3CA-KCNMB3
variants and their interaction with dietary n-3: n-6 PUFA
ratio for HOMA-IR in GOLDN.
(DOCX)
Acknowledgments
We thank the participants and research staff of the Genetics of Lipid
Lowering Drugs and Diet Network (GOLDN) study and the Boston Puerto
Rican Health Study (BPRHS).
Author Contributions
Conceived and designed the experiments: CQL JMO DKA IBB KLT.
Analyzed the data: JSZ CQL. Wrote the paper: JSZ CQL DL. Manuscript
editing: YCL YM CES LDP KR.
References
1. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of
diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4–14.
2. Kelly GS (2000) Insulin resistance: lifestyle and nutritional interventions. Altern
Med Rev 5: 109–132.
3. Riserus U (2008) Fatty acids and insulin sensitivity. Curr Opin Clin Nutr Metab
Care 11: 100–105.
4. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, et al. (2002) Effects of
purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood
pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
Am J Clin Nutr 76: 1007–1015.
5. Mostad IL, Bjerve KS, Bjorgaas MR, Lydersen S, Grill V (2006) Effects of n-3
fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and
time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr
84: 540–550.
6. Abete I, Parra D, Crujeiras AB, Goyenechea E, Martinez JA (2008) Specific
insulin sensitivity and leptin responses to a nutritional treatment of obesity via a
combination of energy restriction and fatty fish intake. J Hum Nutr Diet 21:
591–600.
7. Djousse L, Gaziano JM, Buring JE, Lee IM (2011) Dietary omega-3 fatty acids
and fish consumption and risk of type 2 diabetes. Am J Clin Nutr 93: 143–150.
8. Nanri A, Mizoue T, Noda M, Takahashi Y, Matsushita Y, et al. (2011) Fish
intake and type 2 diabetes in Japanese men and women: the Japan Public Health
Center-based Prospective Study. Am J Clin Nutr 94: 884–891.
9. Villegas R, Xiang YB, Elasy T, Li HL, Yang G, et al. (2011) Fish, shellfish, and
long-chain n-3 fatty acid consumption and risk of incident type 2 diabetes in
middle-aged Chinese men and women. Am J Clin Nutr 94: 543–551.
10. Zheng JS, Huang T, Yang J, Fu YQ, Li D (2012) Marine n-3 polyunsaturated
fatty acids are inversely associated with risk of type 2 diabetes in Asians: a
systematic review and meta-analysis. PLoS ONE 2012;7: e44525. doi:10.1371/
journal.pone.0044525.
11. Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, et al. (2008) Omega-3
polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane
Database Syst Rev: CD003205.
12. Akinkuolie AO, Ngwa JS, Meigs JB, Djousse L (2011) Omega-3 polyunsaturated
fatty acid and insulin sensitivity: A meta-analysis of randomized controlled trials.
Clin Nutr 30: 702–707.
13. Kroger J, Zietemann V, Enzenbach C, Weikert C, Jansen EH, et al. (2011)
Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary
fatty acids in relation to risk of type 2 diabetes in the European Prospective
Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr
93: 127–142.
14. Lee YC, Lai CQ, Ordovas JM, Parnell LD (2011) A Database of Gene-
Environment Interactions Pertaining to Blood Lipid Traits, Cardiovascular
Disease and Type 2 Diabetes. J Data Mining Genomics Proteomics 2: 106.
15. Corella D, Ordovas JM (2012) Interactions between dietary n-3 fatty acids and
genetic variants and risk of disease. Br J Nutr 107: S271–S283.
16. Cornelis MC, Hu FB (2012) Gene-Environment Interactions in the Develop-
ment of Type 2 Diabetes: Recent Progress and Continuing Challenges. Annu
Rev Nutr 32: 245–259.
17. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296: 1655–
1657.
18. Boura-Halfon S, Zick Y (2009) Phosphorylation of IRS proteins, insulin action,
and insulin resistance. Am J Physiol Endocrinol Metab 296: E581–591.
19. Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, et al.
(2006) A pharmacological map of the PI3-K family defines a role for p110alpha
in insulin signaling. Cell 125: 733–747.
20. Sopasakis VR, Liu PX, Suzuki R, Kondo T, Winnay J, et al. (2010) Specific
Roles of the p110 alpha Isoform of Phosphatidylinsositol 3-Kinase in Hepatic
Insulin Signaling and Metabolic Regulation. Cell Metabol 11: 220–230.
21. Foukas LC, Claret M, Pearce W, Okkenhaug K, Meek S, et al. (2006) Critical
role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic
regulation. Nature 441: 366–370.
22. Dufer M, Neye Y, Horth K, Krippeit-Drews P, Hennige A, et al. (2011) BK
channels affect glucose homeostasis and cell viability of murine pancreatic beta
cells. Diabetologia 54: 423–432.
23. Houamed KM, Sweet IR, Satin LS (2010) BK channels mediate a novel ionic
mechanism that regulates glucose-dependent electrical activity and insulin
secretion in mouse pancreatic beta-cells. J Physiol 588: 3511–3523.
24. Corella D, Arnett DK, Tsai MY, Kabagambe EK, Peacock JM, et al. (2007)
The-256T.C polymorphism in the apolipoprotein A-II gene promoter is
associated with body mass index and food intake in the genetics of lipid lowering
drugs and diet network study. Clin Chem 53: 1144–1152.
25. Tucker KL, Mattei J, Noel SE, Collado BM, Mendez J, et al. (2010) The Boston
Puerto Rican Health Study, a longitudinal cohort study on health disparities in
Puerto Rican adults: challenges and opportunities. BMC Public Health 10: 107.
26. Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, et al. (1996) NHLBI
Family Heart Study: objectives and design. Am J Epidemiol 143: 1219–1228.
27. Lai CQ, Tucker KL, Choudhry S, Parnell LD, Mattei J, et al. (2009) Population
admixture associated with disease prevalence in the Boston Puerto Rican health
study. Hum Genet 125: 199–209.
28. Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, et al. (2001)
Comparative validation of the Block, Willett, and National Cancer Institute food
frequency questionnaires : the Eating at America’s Table Study. Am J Epidemiol
154: 1089–1099.
29. Thompson FE, Subar AF, Brown CC, Smith AF, Sharbaugh CO, et al. (2002)
Cognitive research enhances accuracy of food frequency questionnaire reports:
results of an experimental validation study. J Am Diet Assoc 102: 212–225.
30. Tucker KL, Bianchi LA, Maras J, Bermudez OI (1998) Adaptation of a food
frequency questionnaire to assess diets of Puerto Rican and non-Hispanic adults.
Am J Epidemiol 148: 507–518.
31. de Bakker PI, Yelensky R, Pe’er I, Gabriel SB, Daly MJ, et al. (2005) Efficiency
and power in genetic association studies. Nat Genet 37: 1217–1223.
32. Box GEP, Cox DR (1964) An Analysis of Transformations. J R Stat Soc B 26:
211–252.
33. Chen MH, Yang Q (2010) GWAF: an R package for genome-wide association
analyses with family data. Bioinformatics 26: 580–581.
34. Wallin A, Di Giuseppe D, Orsini N, Patel PS, Forouhi NG, et al. (2012) Fish
consumption, dietary long-chain n-3 fatty acids, and risk of type 2 diabetes:
systematic review and meta-analysis of prospective studies. Diabetes Care 35:
918–929.
35. Xun P, He K (2012) Fish Consumption and Incidence of Diabetes: Meta-
analysis of data from 438,000 individuals in 12 independent prospective cohorts
with an average 11-year follow-up. Diabetes Care 35: 930–938.
36. Dedoussis GV, Kaliora AC, Panagiotakos DB (2007) Genes, diet and type 2
diabetes mellitus: a review. Rev Diabet Stud 4: 13–24.
37. Watanabe RM (2010) The genetics of insulin resistance: Where’s Waldo? Curr
Diab Rep 10: 476–484.
38. Marin C, Perez-Jimenez F, Gomez P, Delgado J, Paniagua JA, et al. (2005) The
Ala54Thr polymorphism of the fatty acid-binding protein 2 gene is associated
with a change in insulin sensitivity after a change in the type of dietary fat.
Am J Clin Nutr 82: 196–200.
39. Corella D, Qi L, Tai ES, Deurenberg-Yap M, Tan CE, et al. (2006) Perilipin
gene variation determines higher susceptibility to insulin resistance in Asian
women when consuming a high-saturated fat, low-carbohydrate diet. Diabetes
Care 29: 1313–1319.
40. Smith CE, Arnett DK, Corella D, Tsai MY, Lai CQ, et al. (2010) Perilipin
polymorphism interacts with saturated fat and carbohydrates to modulate insulin
resistance. Nutr Metab Cardiovasc Dis 22: 449–455.
41. Marin C, Perez-Martinez P, Delgado-Lista J, Gomez P, Rodriguez F, et al.
(2011) The insulin sensitivity response is determined by the interaction between
the G972R polymorphism of the insulin receptor substrate 1 gene and dietary
fat. Mol Nutr Food Res 55: 328–335.
PUFA-Gene Interaction on Insulin Resistance
PLOS ONE | www.plosone.org 7 June 2013 | Volume 8 | Issue 6 | e67394
42. Richardson K, Lai CQ, Parnell LD, Lee YC, Ordovas JM (2011) A Genome-
wide survey for SNPs altering microRNA seed sites identifies functional
candidates in GWAS. BMC Genomics 12: 504.
43. Liao W, Nguyen MT, Yoshizaki T, Favelyukis S, Patsouris D, et al. (2007)
Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by
affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes. Am J Physiol
Endocrinol Metab 293: E219–227.
44. Picard F, Auwerx J (2002) PPAR(gamma) and glucose homeostasis. Annu Rev
Nutr 22: 167–197.
45. Wang RX, Chai Q, Lu T, Lee HC (2011) Activation of vascular BK channels by
docosahexaenoic acid is dependent on cytochrome P450 epoxygenase activity.
Cardiovasc Res 90: 344–352.
46. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010)
A method and server for predicting damaging missense mutations. Nat Methods
7: 248–249.
47. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New
genetic loci implicated in fasting glucose homeostasis and their impact on type 2
diabetes risk. Nat Genet 42: 105–116.
48. Hu S, Labuda MZ, Pandolfo M, Goss GG, McDermid HE, et al. (2003)
Variants of the KCNMB3 regulatory subunit of maxi BK channels affect
channel inactivation. Physiol Genomics 15: 191–198.
PUFA-Gene Interaction on Insulin Resistance
PLOS ONE | www.plosone.org 8 June 2013 | Volume 8 | Issue 6 | e67394
